Last reviewed · How we verify
NCT04532437
Computer-based Skin Aging Simulation for Skin Cancer Prevention
trial testing artificial intelligence-based skin aging simulation in Skin Aging in 60 participants. Completed in 19 March 2021.
19 March 2021
Quick facts
| Lead sponsor | University Hospital, Basel, Switzerland |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 9 February 2021 |
| Primary completion | 19 March 2021 |
| Estimated completion | 19 March 2021 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- artificial intelligence-based skin aging simulation
- electronic questionnaire 1
- electronic questionnaire 2
Conditions studied
- Skin Aging — all drugs for Skin Aging →
Sponsor
University Hospital, Basel, Switzerland
Who can join
Adults 18 to 35, female only, with Skin Aging. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This pilot study is to assess the knowledge, attitudes, and practices regarding skin cancer prevention in young adults and to determine the impact of artificial intelligence-based simulation of facial skin aging on their attitudes regarding skin cancer prevention.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Artificial Intelligence-Driven Skin Aging Simulation as a Novel Skin Cancer Prevention.
Gantenbein L, Cerminara SE, Maul JT, Navarini AA, et al · · 2025 · cited 3× · PMID 39401496 · DOI 10.1159/000541943
Verify or expand the search:
- PubMed search for NCT04532437
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Skin Aging
Currently open trials in the same condition.
- NCT07381218 — Focused Ultrasound Treatment for Facial Skin Laxity · NA · active not recruiting
- NCT06900660 — Evaluation of the Skin-Beautifying Effects of Collagen Drinks · NA · active not recruiting
- NCT06804772 — A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the · NA · active not recruiting
- NCT06816069 — Study on Safety and Efficacy of Monopolar Radio Frequency Device for Facial Skin Tightening · NA · active not recruiting
- NCT06727292 — Biometrical Evaluation of the Efficacy of a Food Supplement Versus Placebo · NA · recruiting
Other University Hospital, Basel, Switzerland trials
Trials by the same sponsor.
- NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
- NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
- NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
- NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
- NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04532437 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
- Last refreshed: 15 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04532437.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing